Biocept Inc logo

BIOC - Biocept Inc News Story

$4.36 -0.0  -0.7%

Last Trade - 16/04/21

Sector
Healthcare
Size
Micro Cap
Market Cap £42.3m
Enterprise Value £33.6m
Revenue £19.9m
Position in Universe 5515th / 6850

BRIEF-Study Shows Biocept's Assays Are Viable, Sensitive For Detecting Tumor Cells, Biomarkers In The Cerebrospinal Fluid Of Patients With Breast, Lung Cancer

Fri 20th November, 2020 1:08pm
Nov 20 (Reuters) - Biocept Inc  BIOC.O :
    * STUDY SHOWS BIOCEPT'S ASSAYS ARE VIABLE AND SENSITIVE FOR
DETECTING TUMOR CELLS AND BIOMARKERS IN THE CEREBROSPINAL FLUID
OF PATIENTS WITH BREAST AND LUNG CANCER THAT HAS METASTASIZED TO
THE CENTRAL NERVOUS SYSTEM

Source text for Eikon:  ID:nPnPh9zka 
Further company coverage:  BIOC.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.